Ruplizumab, CAS [[220651-94-5]]

Produktübersicht

• Artikelname: Ruplizumab, CAS [[220651-94-5]]
• Artikelnummer: MCE-HY-P99315
• Hersteller Artikelnummer: HY-P99315
• Alternativnummer: MCE-HY-P99315-25MG,MCE-HY-P99315-10MG,MCE-HY-P99315-5MG,MCE-HY-P99315-1MG,MCE-HY-P99315-50MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: BG 9588, Anti-Human CD40L Recombinant Antibody, Hu5c8

Produktbeschreibung

Ruplizumab (BG 9588) is a humanized anti-CD40L IgG1kappa monoclonal antibody. By binding to CD40L, Ruplizumab blocks its interaction with the CD40 receptor, inhibits T-B cell costimulatory signals, and mediates the depletion of activated T cells via the Fc segment. Ruplizumab has immunosuppressive effects. Ruplizumab can be used in the study of systemic lupus erythematosus, organ transplant rejection, and autoimmune diseases. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2].

Produkteigenschaften

• Molekulargewicht: (145.68 kDa)
• Reinheit: 99.84
• CAS Nummer: [220651-94-5]
• Target-Kategorie: TNF Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies